These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 14627183

  • 1. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
    Ebeling PR, Russell RG.
    Int J Clin Pract; 2003 Oct; 57(8):710-8. PubMed ID: 14627183
    [Abstract] [Full Text] [Related]

  • 2. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT, Christensen PM, Ejersted C, Langdahl BL.
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [Abstract] [Full Text] [Related]

  • 3. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD, Hanley DA, Lorraine JK, Yu M.
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [Abstract] [Full Text] [Related]

  • 4. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF, Hamdy NA, Netelenbos JC.
    Ned Tijdschr Geneeskd; 2006 Jan 21; 150(3):132-7. PubMed ID: 16463613
    [Abstract] [Full Text] [Related]

  • 5. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S, Sorbello L, Puglisi N, Grasso S, La Malfa L, D'Urbino G, Rizzotto M, Strano S, Maugeri D.
    Arch Gerontol Geriatr; 2007 Jan 21; 44 Suppl 1():249-58. PubMed ID: 17317460
    [Abstract] [Full Text] [Related]

  • 6. The prevention and treatment of osteoporosis: a review.
    Cosman F.
    MedGenMed; 2005 May 11; 7(2):73. PubMed ID: 16369451
    [Abstract] [Full Text] [Related]

  • 7. Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.
    Lindsay R, Scheele WH, Neer R, Pohl G, Adami S, Mautalen C, Reginster JY, Stepan JJ, Myers SL, Mitlak BH.
    Arch Intern Med; 2004 Oct 11; 164(18):2024-30. PubMed ID: 15477438
    [Abstract] [Full Text] [Related]

  • 8. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
    Delmas PD, Licata AA, Reginster JY, Crans GG, Chen P, Misurski DA, Wagman RB, Mitlak BH.
    Bone; 2006 Aug 11; 39(2):237-43. PubMed ID: 16563890
    [Abstract] [Full Text] [Related]

  • 9. [Treatment with recombinant parathyroid hormone of advanced osteoporosis--series of cases].
    Skiba K, Adamczak M, Wiecek A.
    Przegl Lek; 2011 Aug 11; 68(7):391-5. PubMed ID: 22010479
    [Abstract] [Full Text] [Related]

  • 10. Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.
    Prescrire Int; 2005 Feb 11; 14(75):5-9. PubMed ID: 15747448
    [Abstract] [Full Text] [Related]

  • 11. Treatment of osteoporosis with parathyroid hormone and teriparatide.
    Pleiner-Duxneuner J, Zwettler E, Paschalis E, Roschger P, Nell-Duxneuner V, Klaushofer K.
    Calcif Tissue Int; 2009 Mar 11; 84(3):159-70. PubMed ID: 19189037
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of osteoporosis due to ovarian failure.
    Eastell R.
    Med Pediatr Oncol; 2003 Sep 11; 41(3):222-7. PubMed ID: 12868123
    [Abstract] [Full Text] [Related]

  • 14. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
    Miller RG.
    Geriatrics; 2006 Jan 11; 61(1):24-30. PubMed ID: 16405361
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bone health and osteoporosis in postmenopausal women.
    de Villiers TJ.
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb 11; 23(1):73-85. PubMed ID: 19027366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Teriparatide for severe osteoporosis.
    Cappuzzo KA, Delafuente JC.
    Ann Pharmacother; 2004 Feb 11; 38(2):294-302. PubMed ID: 14742769
    [Abstract] [Full Text] [Related]

  • 19. [Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection].
    Sowa H, Hamaya E, Yamamoto T.
    Clin Calcium; 2011 Jan 11; 21(1):9-16. PubMed ID: 21187589
    [Abstract] [Full Text] [Related]

  • 20. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D, Frey D, Frey-Rindova P, Goerres G, Michel BA.
    Z Rheumatol; 2003 Dec 11; 62(6):512-7. PubMed ID: 14685711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.